Lignende værker: 50 Years of Immunization—Steps Forward
- Why vaccines to HIV, HCV and Malaria have so far failed - Challenges to developing vaccines against immunoregulating pathogens
- mLife
- ImmunoMedicine
- Global Health Research and Policy
- Dynamical Models of Biology and Medicine
- Public Health Challenges
- BMC Medicine
- Integrative Multi-Omics in Biomedical Research
- BMC Public Health
- International Journal of One Health
- Journal of the International AIDS Society
- npj Health Systems
- Health Care Science
- BJPsych International
- Jurnal Ilmiah Kesehatan Sandi Husada
- GeoHealth
- Tobacco Prevention and Cessation
- Health Economics, Policy and Law
- Annals of Global Health
- Global Challenges
- Clinovate: Advances in Medicine and Healthcare
- Health Expectations
- Acta Universitatis Danubius: Administratio
- Gazeta Médica
Emne: non-COVID-19 vaccine
- Emne: South Kivu
- Emne: immunization
- Emne: vaccine misinformation
- Emne: vaccine reactogenicity
- Emne: adverse reactions
- Emne: adverse events following immunization
- Emne: vaccine injury compensation program
- Emne: cholera
- Emne: oral cholera vaccine
- Emne: vaccination campaign
- Emne: cost
- Emne: cost-effectiveness
- Emne: integration
- Emne: vaccination
- Emne: service delivery
- Emne: systematic review
- Emne: maternal and child health
- Emne: infant
- Emne: HIV
- Emne: malaria
- Emne: family planning
- Emne: poliomyelitis
- Emne: epidemiology
- Emne: vaccine coverage
- Emne: surveillance
- Emne: polio eradication
- Emne: pertussis
- Emne: vaccines
- Emne: diagnosis
- Emne: vaccine security
- Emne: global OPV stockpile
- Emne: immunization policy
- Emne: inactivated poliovirus vaccine (IPV)
- Emne: oral poliovirus vaccine (OPV)
- Emne: vaccine production and distribution
- Emne: global health security
- Emne: poliovirus containment
- Emne: vaccine
- Emne: microplanning
- Emne: microplan
- Emne: LMIC
- Emne: routine childhood vaccines
- Emne: newcomer
- Emne: immunizations
- Emne: access
- Emne: equity
- Emne: qualitative methods
- Emne: Strategic Advisory Group of Experts (SAGE) on Immunization
- Emne: SAGE
- Emne: World Health Organization advisory group
- Emne: global immunization policy
- Emne: immunization strategy
- Emne: vaccination policy
- Emne: vaccination recommendations
- Emne: vaccine hesitancy
- Emne: cancer
- Emne: pediatric
- Emne: immunocompromised
- Emne: public health
- Emne: influenza
- Emne: COVID-19
- Emne: respiratory syncytial virus
- Emne: outbreaks
- Emne: maternal vaccination
- Emne: vaccination week in the Americas
- Emne: pandemic preparedness and response
- Emne: life-course immunization
- Emne: coverage increase
- Emne: zero-dose
- Emne: LMICs
- Emne: hepatitis E
- Emne: HEV 239
- Emne: shorter schedule
- Emne: immunogenicity
- Emne: efficacy
- Emne: zero dose
- Emne: under-five vaccination
- Emne: human centered design
- Emne: advocacy
- Emne: community-centric intervention
- Emne: National Immunization Technical Advisory Groups
- Emne: NITAGs
- Emne: WHO–UNICEF Joint Reporting Form
- Emne: measles
- Emne: under-immunized
- Emne: vaccine inequity
- Emne: herpes zoster
- Emne: varicella zoster virus
- Emne: health policy
- Emne: Central Africa
- Emne: big catch-up
- Emne: peer learning
- Emne: measles, mumps, and rubella
- Emne: MMR
- Emne: Denmark
- Emne: school
- Emne: healthcare
- Emne: education
- Emne: economic outcomes
- Emne: HPV vaccination
- Emne: girls
- Emne: supplementary immunization activities
- Emne: coverage
- Emne: disparities
- Emne: Togo
- Emne: immunization equity
- Emne: children with disabilities
- Emne: low- and middle-income countries
- Emne: vaccine barriers
- Emne: vaccination strategies
- Emne: inclusive healthcare
- Emne: adult
- Emne: health workers
- Emne: pregnant women
- Emne: elderly
- Emne: chronic diseases
- Emne: Shigella
- Emne: children
- Emne: phase III study
- Emne: endpoints
- Emne: safety
- Emne: dengue
- Emne: Qdenga
- Emne: CYD-TDV
- Emne: TAK-003
- Emne: Wolbachia
- Emne: antibody-dependent enhancement
- Emne: mRNA vaccines
- Emne: school-based programs
- Emne: n/a
- Emne: thema EDItEUR::M Medicine and Nursing
Emne: Vibrio cholerae
- Emne: South Kivu
- Emne: immunization
- Emne: vaccine misinformation
- Emne: vaccine reactogenicity
- Emne: adverse reactions
- Emne: adverse events following immunization
- Emne: vaccine injury compensation program
- Emne: cholera
- Emne: oral cholera vaccine
- Emne: vaccination campaign
- Emne: cost
- Emne: cost-effectiveness
- Emne: integration
- Emne: vaccination
- Emne: service delivery
- Emne: systematic review
- Emne: maternal and child health
- Emne: infant
- Emne: HIV
- Emne: malaria
- Emne: family planning
- Emne: poliomyelitis
- Emne: epidemiology
- Emne: vaccine coverage
- Emne: surveillance
- Emne: polio eradication
- Emne: pertussis
- Emne: vaccines
- Emne: diagnosis
- Emne: vaccine security
- Emne: global OPV stockpile
- Emne: immunization policy
- Emne: inactivated poliovirus vaccine (IPV)
- Emne: oral poliovirus vaccine (OPV)
- Emne: vaccine production and distribution
- Emne: global health security
- Emne: poliovirus containment
- Emne: vaccine
- Emne: microplanning
- Emne: microplan
- Emne: LMIC
- Emne: routine childhood vaccines
- Emne: newcomer
- Emne: immunizations
- Emne: access
- Emne: equity
- Emne: qualitative methods
- Emne: Strategic Advisory Group of Experts (SAGE) on Immunization
- Emne: SAGE
- Emne: World Health Organization advisory group
- Emne: global immunization policy
- Emne: immunization strategy
- Emne: vaccination policy
- Emne: vaccination recommendations
- Emne: vaccine hesitancy
- Emne: cancer
- Emne: pediatric
- Emne: immunocompromised
- Emne: public health
- Emne: influenza
- Emne: COVID-19
- Emne: respiratory syncytial virus
- Emne: outbreaks
- Emne: maternal vaccination
- Emne: vaccination week in the Americas
- Emne: pandemic preparedness and response
- Emne: life-course immunization
- Emne: coverage increase
- Emne: zero-dose
- Emne: LMICs
- Emne: hepatitis E
- Emne: HEV 239
- Emne: shorter schedule
- Emne: immunogenicity
- Emne: efficacy
- Emne: zero dose
- Emne: under-five vaccination
- Emne: human centered design
- Emne: advocacy
- Emne: community-centric intervention
- Emne: National Immunization Technical Advisory Groups
- Emne: NITAGs
- Emne: WHO–UNICEF Joint Reporting Form
- Emne: measles
- Emne: under-immunized
- Emne: vaccine inequity
- Emne: herpes zoster
- Emne: varicella zoster virus
- Emne: health policy
- Emne: Central Africa
- Emne: big catch-up
- Emne: peer learning
- Emne: measles, mumps, and rubella
- Emne: MMR
- Emne: Denmark
- Emne: school
- Emne: healthcare
- Emne: education
- Emne: economic outcomes
- Emne: HPV vaccination
- Emne: girls
- Emne: supplementary immunization activities
- Emne: coverage
- Emne: disparities
- Emne: Togo
- Emne: immunization equity
- Emne: children with disabilities
- Emne: low- and middle-income countries
- Emne: vaccine barriers
- Emne: vaccination strategies
- Emne: inclusive healthcare
- Emne: adult
- Emne: health workers
- Emne: pregnant women
- Emne: elderly
- Emne: chronic diseases
- Emne: Shigella
- Emne: children
- Emne: phase III study
- Emne: endpoints
- Emne: safety
- Emne: dengue
- Emne: Qdenga
- Emne: CYD-TDV
- Emne: TAK-003
- Emne: Wolbachia
- Emne: antibody-dependent enhancement
- Emne: mRNA vaccines
- Emne: school-based programs
- Emne: n/a
- Emne: thema EDItEUR::M Medicine and Nursing